Greg Zarbis-Papastoitsis
Nessuna posizione attualmente
Profilo
Greg Zarbis-Papastoitsis worked as the Head of Process Sciences & Manufacturing at Sesen Bio, Inc. from 2013 to 2016.
He received his undergraduate and doctorate degrees from the State University of New York at Binghamton.
Precedenti posizioni note di Greg Zarbis-Papastoitsis
| Società | Posizione | Fine |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2016 |
Formazione di Greg Zarbis-Papastoitsis
| State University of New York at Binghamton | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Greg Zarbis-Papastoitsis
